Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: TechSci Research | PRODUCT CODE: 1223996

Cover Image

PUBLISHER: TechSci Research | PRODUCT CODE: 1223996

Vietnam Over The Counter Drugs Market, By Product, By Route of Administration, By Dosage Form, By Distribution Channel, By Region, Competition Forecast & Opportunities, 2027

PUBLISHED:
PAGES: 75 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4400
PDF and Excel (Multi-User License)
USD 5400
PDF and Excel (Custom Research License)
USD 8400

Add to Cart

We offer 8 hour analyst time for an additional research. Please contact us for the details.

Vietnam over the counter (OTC) drugs market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027, on the account of expanding pharmaceutical industry of the country. Vietnam's healthcare industry does not have the capable resources for consistent research and advancement in drug designing, pharmacy advancement, etc. Therefore, the local pharmaceutical manufacturers and contract manufacturing organizations are solely invested in the manufacturing of generics, biosimilars, and over-the-counter (OTC) drugs, thus driving the growth of Vietnam over the counter (OTC) drugs market in the upcoming five years.

Over-the-counter, (OTC) drugs are non-prescription-based medicines that are usually sold without any legal prescription and are often with no side effects. These drugs are safe and do not have any addictive nature if consumed un-monitored or without a physician's prescription. Although, as a general awareness physicians often advise to consult doctors and experts regarding illness before self-prescribing any kind of medicine. Basic cold medicines, vitamin tablets, or health supplements are different categories of over-the-counter (OTC) drugs.

Expanding Pharmaceutical Industry Satisfies Demand

Demand for counter (OTC) drugs is expediting due to rapid demands from the common population of the country. Although, due to the increasing population that can spend more on branded drugs and new advanced medicine, still a large portion of the total population, exceeding 98 million population is inclined toward generic drugs, OTC drugs, and biosimilars. The growing pharmaceutical industry is also stabilized due to the consistent flow of investments in the form of government financial assistance.

In the year, 2018 Vietnam's pharmaceutical industry was valued at USD5.34 billion. The industrial production index in the year exceeded 121.8 in the year 2020, demonstrating higher production and manufacturing of pharmaceutical products like OTC drugs, thus substantiating the growth of the Vietnam OTC drugs market in the future five years.

Market Segmentation

The Vietnam over-the-counter (OTC) drugs market is segmented by product, route of administration, dosage forms, distribution channel, competitional landscape, and regional distribution. Based on product, the market is further segmented into a cough, cold, and flu; vitamins, minerals, and supplements (VMS); analgesics; gastrointestinal products; dermatology products; and others. The market is also fragmented based on the route of administration of the drugs into oral, topical, and parenteral. Based on dosage form, the market is bifurcated into tablets, capsules, liquids & solutions, creams/ lotions/ ointments, and others. By distribution channel, the market is differentiated into retail pharmacy, hospital pharmacy, and e-pharmacy. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among Northern region, Central region, and the Southern region.

Company Profile

Sanofi-Aventis Vietnam Company, GlaxoSmithKline Vietnam, Reckitt Benckiser Vietnam, Imexpharm Pharmaceutical Joint Stock Company, DHG Pharmaceutical Joint Stock Company, Traphaco Joint Stock Company, Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company, Vimedimex Medi-Pharma Joint Stock Company, Vietnam Pharmaceutical Corporation, Ha Tay Pharmaceutical Joint Stock Company, among others is a partial list of major market players of the companies responsible for the growth of Vietnam over the counter (OTC) drugs market.

Report Scope:

In this report, Vietnam over the counter (OTC) drugs market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Vietnam Over The Counter (OTC) Drugs Market, By Product:

Cough, Cold, and Flu

Vitamins, Mineral, and Supplements (VMS)

Analgesics

Gastrointestinal Products

Dermatology Products

Others

  • Vietnam Over The Counter (OTC) Drugs Market, By Route of Administration:

Oral

Topical

Parenteral

  • Vietnam Over the counter (OTC) drugs Market, By Dosage Form:

Tablets

Capsules

Liquids & Solution

Creams/Lotions/Ointments

Others

  • Vietnam Over The Counter (OTC) Drugs Market, By Distribution Channel:

Retail Pharmacy

Hospital Pharmacy

E-Pharmacy

  • Vietnam Over The Counter (OTC) Drugs Market, By Region:

Northern Region

Central Region

Southern Region

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Vietnam over the counter (OTC) drugs market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Product Code: 9518

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Vietnam Over the counter (OTC) drugs (OTC) Drugs Market

4. Executive Summary

5. Voice of Customers

6. Vietnam Over the counter (OTC) drugs (OTC) Drugs Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Cough, Cold and Flu; Vitamins, Mineral, and Supplements (VMS); Analgesics; Gastrointestinal Products; Dermatology Products; Others)
    • 6.2.2. By Route of Administration (Oral, Topical, Parenteral)
    • 6.2.3. By Dosage Form (Tablets, Capsules, Liquids & Solution, Creams/Lotions/Ointments, Others)
    • 6.2.4. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)
    • 6.2.5. By Region
    • 6.2.6. By Company (2021)
  • 6.3. Product Market Map

7. Vietnam Cough, Cold and Flu Over the counter (OTC) drugs (OTC) Drugs Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Route of Administration
    • 7.2.2. By Dosage Form
    • 7.2.3. By Distribution Channel

8. Vietnam Vitamins, Mineral and Supplements (VMS) Over the counter (OTC) drugs (OTC) Drugs Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Route of Administration
    • 8.2.2. By Dosage Form
    • 8.2.3. By Distribution Channel

9. Vietnam Analgesics Over the counter (OTC) drugs (OTC) Drugs Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Route of Administration
    • 9.2.2. By Dosage Form
    • 9.2.3. By Distribution Channel

10. Vietnam Gastrointestinal Over the counter (OTC) drugs (OTC) Drugs Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Route of Administration
    • 10.2.2. By Dosage Form
    • 10.2.3. By Distribution Channel

11. Vietnam Dermatology Over the counter (OTC) drugs (OTC) Drugs Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Route of Administration
    • 11.2.2. By Dosage Form
    • 11.2.3. By Distribution Channel

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Policy & Regulatory Landscape

15. Vietnam Economic Profile

16. Competitive Landscape

  • 16.1. Competition Outlook
  • 16.2. Company Profiles
    • 16.2.1. Sanofi-Aventis Vietnam Company
    • 16.2.2. GlaxoSmithKline Vietnam
    • 16.2.3. Reckitt Benckiser Vietnam
    • 16.2.4. Imexpharm Pharmaceutical Joint Stock Company
    • 16.2.5. DHG Pharmaceutical Joint Stock Company
    • 16.2.6. Traphaco Joint Stock Company
    • 16.2.7. Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company
    • 16.2.8. Vimedimex Medi-Pharma Joint Stock Company
    • 16.2.9. Vietnam Pharmaceutical Corporation
    • 16.2.10. Ha Tay Pharmaceutical Joint Stock Company

17. Strategic Recommendations

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!